Axillary sentinel lymph node biopsy: an overview.
The sentinel lymph node biopsy has become the standard procedure in the staging and management of axillary lymph nodes in early breast cancer. This procedure has been validated by several studies with an accuracy of 95% and a false-negative rate ranging from 5 to 15%. Aim of this study is to analyze the most updated results and open problems reported in literature in the use of sentinel node biopsy in breast surgery.